Andreas Hillarp
Overview
Explore the profile of Andreas Hillarp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
426
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sunnersjo L, Lindquist L, Schott U, Hillarp A, Unden J, Kander T
Scand J Clin Lab Invest
. 2024 Dec;
84(7-8):540-546.
PMID: 39673538
Direct oral anticoagulants (DOAC) are increasingly common, with bleeding events associated with elevated plasma concentrations. Rotational thromboelastometry (ROTEM), a point-of-care tool for assessing secondary hemostasis, has demonstrated a correlation with...
2.
Sunnersjo L, Ymen I, Schott U, Hillarp A, Unden J, Kander T
Thromb J
. 2024 Oct;
22(1):91.
PMID: 39425155
Background: Hypothermia and acidosis individually inhibit haemostasis. We designed this study with the aim to investigate whether rivaroxaban combined with hypothermia or acidosis exhibit synergistic inhibitory effects on haemostasis using...
3.
Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management
Jorgensen O, Steineger J, Hillarp A, Pareli Waland E, Holme P, Heimdal K, et al.
Laryngoscope Investig Otolaryngol
. 2024 Feb;
9(1):e1196.
PMID: 38362186
Objectives: The objective of this study was twofold: to determine the prevalence of arterial and venous thromboembolic events in the Norwegian Hereditary Hemorrhagic Telangiectasia (HHT) population, and to explore potential...
4.
Hillarp A, Holme P, Waland E, Le M, Henriksson C, Tjonnfjord G, et al.
J Thromb Haemost
. 2023 Aug;
21(10):2771-2775.
PMID: 37543216
Background: The immunogenicity, safety, and efficacy of recombinant factor VIII (rFVIII) have gained increasing interest after the introduction of extended half-life products with various modifications of the rFVIII molecule, such...
5.
Bauca J, Ajzner E, Cadamuro J, Hillarp A, Kristoffersen A, Meijer P
Clin Chim Acta
. 2022 Sep;
535:174-179.
PMID: 36055391
Background: Providing evidence-based interpretative comments (IC) is an integral task of clinical laboratory professionals. It may be of special relevance for coagulation testing, where pathological first-line tests could trigger more...
6.
Taune V, Skeppholm M, Agren A, Wikman A, Hillarp A, Wallen H
TH Open
. 2022 Sep;
6(3):e238-e247.
PMID: 36046206
A rapid test to detect apixaban treatment would be useful in acute situations such as major bleeding, urgent surgery, or in acute thrombosis. This article aims to study if the...
7.
Bauca J, Ajzner E, Cadamuro J, Hillarp A, Kristoffersen A, Meijer P
Clin Chim Acta
. 2022 Aug;
535:167-173.
PMID: 36041550
Background: Unexpected prolongation of first-line coagulation tests, including activated partial thromboplastin time (APTT), should trigger further work-up by performing mixing tests to elucidate the underlying cause, direct further specific testing...
8.
Bian L, Baghaei F, Antovic J, Fagerberg Blixter I, Hillarp A, Strandberg K, et al.
Lakartidningen
. 2022 Jun;
119.
PMID: 35713306
Activated partial thromboplastin time (APTT) is widely practiced in preoperative screening. The value of using this test to predict the risk of perioperative bleeding is not well documented in Sweden....
9.
Boknas N, Laine C, Hillarp A, Macwan A, Gustafsson K, Lindahl T, et al.
Thromb Res
. 2022 Mar;
213:97-104.
PMID: 35316719
In this single-center cohort study, we applied a panel of laboratory markers to characterize hemostatic function in 217 consecutive patients that underwent testing for COVID-19 as they were admitted to...
10.
Larsson S, Hellstrom-Westas L, Hillarp A, Karlsland Akeson P, Domellof M, Askelof U, et al.
Arch Dis Child
. 2021 Oct;
107(4):351-358.
PMID: 34674992
Objectives: There is a need for updated haematological reference data in infancy. This study aimed to define intervals for haemoglobin and red blood cell biomarkers based on data from a...